Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer

6 Feb 2019

Abstract excerpt

Whole exome sequencing (WES), targeted gene panel sequencing and single nucleotide polymorphism (SNP) arrays are increasingly used for the identification of actionable alterations that are critical to cancer care. Here, we compared The Cancer Genome Atlas (TCGA) and the Genomics Evidence Neoplasia Information Exchange (GENIE) breast cancer genomic datasets (array and next generation sequencing (NGS) data) in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30728399
DOI: 10.1038/s41598-018-37574-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancerPMID 30728399Read ↗

Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)Semantic proximity Read ↗

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.Semantic proximity Read ↗

Identification of putative actionable alterations in clinically relevant genes in breast cancer.Semantic proximity Read ↗

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.Semantic proximity Read ↗

AI-Driven Variant Annotation for Precision Oncology in Breast CancerSemantic proximity Read ↗

Genetic alterations and their association with clinicopathologic characteristics in advanced breast carcinomas: focusing on clinically actionable genetic alterations.Semantic proximity Read ↗

Tumor Mutational Landscape and Its Correlation with Histopathological Characteristics in Breast CancerSemantic proximity Read ↗

Comprehensive genomic profiling of Taiwanese triple-negative breast cancer with a large targeted sequencing panel.Semantic proximity Read ↗

Targeted mutation detection in breast cancer using MammaSeq™Semantic proximity Read ↗

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesSemantic proximity Read ↗

Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.Semantic proximity Read ↗

Targeted mutation detection in breast cancer using MammaSeq™Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.